San Francisco, 12 November 2018, The global facial injectables market is expected to reach USD 17.2 billion
by 2025, according to a new report by Grand View Research, Inc. The market is
expected to exhibit lucrative growth during the forecast period, owing to
advancements in facial rejuvenation procedures and increasing importance of
medical aesthetics across the globe.
Development in products & procedures,
as well as change in patient demographics is helping dermatologists and
physicians treat multiple facial areas. These advancements help dermatologists
or physicians develop customized treatment for patients and facilitate use of
combination products to obtain better outcomes. All these factors are expected
to assist in the market growth over the forecast period. Augmented products
such as Botulinum Toxin Type A (BoNTA) and Hyaluronic Acid (HA) fillers are
used in combination to improve outcomes, especially in the lower face
procedures. HA fillers are mostly preferred by physicians due to their better
acceptance (few instances of hypersensitivity reactions), biodegradable nature,
& high viscosity as well as for the longevity they provide to the restored
volume.
Minimally invasive surgery, an advanced
medical technology, is used for facial rejuvenation, endoscopy, laparoscopy,
arthroscopy and other procedures. This procedure is gaining popularity over
time owing to faster recovery, low instances of postsurgery infections, lower
pain, reduced scarring, and high accuracy & maximum benefits. For instance,
as per International Society of Aesthetic Plastic Surgery (ISAPS), more than
20.0 million surgical and nonsurgical cosmetic procedures were performed
worldwide in 2014.The number of HA-based surgeries performed in 2014 was
2,690,633, which increased to 2,865,086 in 2015, which is thereby expected to
contribute to the growth of this space over the forecast period.
Full Research Report On Facial Injectables Market Analysis:
www.grandviewresearch.com/industry-analysis/facial-injectables-industry
www.grandviewresearch.com/industry-analysis/facial-injectables-industry
Further key findings from the study suggest:
·
The hyaluronic acid segment held a
lucrative share in 2016 and is expected to grow at a significant rate over the
forecast period owing to increasing preference for combination treatments such
as hyaluronic acid with BoNTA.
·
The BoNTA segment is anticipated to witness
the fastest growth over the forecast period due to increasing application in
aesthetics and therapeutics
·
The aesthetics segment is expected to
dominate the market during the forecast period owing to increasing expenditure
on aesthetic procedures coupled with rising beauty consciousness among
consumers
·
North America is expected to dominate the
facial injectables market over the forecast period due to growing geriatric
population base, increasing consumer disposable income, and surge in number of
facial procedures in the region
·
Some of the key players in facial
injectables market are ALLERGAN; Ipsen; Merz Pharma; Suneva Medical, Inc.;
Medytox, Inc.; Sinclair Pharma; Bloomage BioTechnology Corporation Limited;
Anika Therapeutics, Inc.; Prollenium Medical Technologies Inc.; and Galderma
S.A.
Browse
More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global facial injectables market
on the basis of product, application, and region:
Facial Injectables Product Outlook
(Revenue, USD Million, 2014 - 2025)
·
Collagen
·
Hyaluronic Acid (HA)
·
Botulinum Toxin Type A
·
Calcium Hydroxylapatite (CaHA)
·
Polymer Fillers
o
Polymethylmethacrylate Beads (PMMA
Microspheres)
o
Poly-L-lactic acid (PLLA)
Facial Injectables Application Outlook
(Revenue, USD Million, 2014 - 2025)
·
Aesthetics
·
Therapeutics
Facial Injectables Regional Outlook
(Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
Japan
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
Middle East and Africa (MEA)
o
South Africa
Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-facial-injectables-market
www.grandviewresearch.com/press-release/global-facial-injectables-market
About Grand View Research
Grand View Research, Inc.
is a U.S. based market research and consulting company, registered in the State
of California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/
No comments:
Post a Comment